Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanomas”

3,465 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,465 results

Not applicableStudy completedNCT03348891
What this trial is testing

TNF in Melanoma Patients Treated With Immunotherapy

Who this might be right for
Melanoma
Institut Claudius Regaud 60
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Not applicableLooking for participantsNCT06643286
What this trial is testing

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Who this might be right for
Melanoma (Skin)Melanoma, Stage II, Stage IMelanoma Stage+1 more
Erasmus Medical Center 180
Early research (Phase 1)Study completedNCT01176474
What this trial is testing

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 73
Testing effectiveness (Phase 2)Study completedNCT00938223
What this trial is testing

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 51
Testing effectiveness (Phase 2)Looking for participantsNCT05423262
What this trial is testing

TRK-950 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorMelanoma
Toray Industries, Inc 49
Testing effectiveness (Phase 2)Study completedNCT05217303
What this trial is testing

HL-085 in NRAS-mutated Advanced Melanoma

Who this might be right for
Melanoma
Shanghai Kechow Pharma, Inc. 100
Early research (Phase 1)Looking for participantsNCT06660420
What this trial is testing

Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)

Who this might be right for
Phase 1Recurrent MelanomaRefractory Melanoma
M.D. Anderson Cancer Center 39
Not applicableStudy completedNCT00889980
What this trial is testing

Melanoma Molecular Profiling Analysis

Who this might be right for
Melanoma
University of Pittsburgh 237
Not applicableStudy completedNCT00416988
What this trial is testing

Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants

Who this might be right for
Melanoma (Skin)Weight Changes
Rhode Island Hospital 1,135
Large-scale testing (Phase 3)Study completedNCT00395070
What this trial is testing

Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Who this might be right for
Metastatic Melanoma
Vical 390
Testing effectiveness (Phase 2)Study completedNCT00003362
What this trial is testing

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT01993654
What this trial is testing

In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions

Who this might be right for
NevusRacial MelanosisPrimary Acquired Melanosis+1 more
Massachusetts Eye and Ear Infirmary 17
Early research (Phase 1)Ended earlyNCT00747825
What this trial is testing

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Molecular Insight Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT00112476
What this trial is testing

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage IV Melanoma+2 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00289627
What this trial is testing

A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 155
Not applicableUnknownNCT01002560
What this trial is testing

The Identification of Novel Prognostic Markers in Melanoma

Who this might be right for
Malignant Melanoma
Royal Marsden NHS Foundation Trust 500
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Early research (Phase 1)Ended earlyNCT02668770
What this trial is testing

Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced CancersMelanoma
M.D. Anderson Cancer Center 28
Not applicableStudy completedNCT00785369
What this trial is testing

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Who this might be right for
Skin CancerMelanomaLentigo Maligna
Lucid, Inc. 441
Next Page